Roche will invest CHF 450 million ($467 million) over the next three years to establish a new diagnostic manufacturing facility at the Suzhou Industrial Park, in Suzhou, China. The new manufacturing site sets out to meet demand for diagnostic tests in China and the Asia Pacific region. As a new addition to Roche's global diagnostic production network, the Asia manufacturing facility will focus on producing Immunochemistry and clinical chemistry tests, products needed for clinical laboratory testing. The site plans to build a workforce of over 600 employees over the next several years.

The new Roche Diagnostics manufacturing site will be the eighth worldwide and the first in the Asia Pacific Region. The facility will focus on packaging operations in the first phase and will be fully operational by 2018.

Source: Roche